一种适合于网络专家系统的通用理论(英文)

描述运用于工业自动化的一种自适应自学习方法。基于此方法,Ａｐｔｒｏｎｉｘ公司开发出一套通用软件工具－ＳＴＩＭＴＭ,并应用于不同工业领域。ＳＴＩＭ可用于构造各类专家系统。基于因素空间理论,ＳＴＩＭ具有一系列独特之处,比如自动化、自学习,以及自翻译。如果与因特网,嵌入式控制器以及可编程逻辑控制器等结合使用,ＳＴＩＭ则成为一个十分有效的工具,可应用于远程连通与控制、模式识别、机器故障诊断,以及自动化加工过程中的传感器数据融合     

(3H) spiroperidol binding decreases in brains of rats infected with Venezuelan equine encephalomyelitis virus1

Summary After i.p. inoculation with the Guajira strain of Venezuelan equine encephalomyelitis virus a significant decrease in the density of (³H) spiroperidol binding sites in the striatum, midbrain and frontal cortex was observed. No changes in the affinity of the receptors could be demonstrated. This finding is compatible with neuronal degeneration caused by the viral infection.Acknowledgments. This work was partially supported by Condes-Luz and Fundacite-Zulia. Butaclamol isomers were a gift of Ayerst Laboratories, Montreal, Canada.     

克拉2气田石油地质特征

克拉2气田位于库车拗陷克拉苏构造带中段, 是双重构造中呈串珠状分布的一系列褶皱中的一个局部构造. 含气层系以下白垩统巴什基奇克组砂岩为主, 其次为下第三系库姆格列木群白云岩段和砂砾岩段及下白垩统巴西盖组砂岩. 天然气中甲烷含量大于97%, 属于干气, 气源为侏罗系煤系地层. 克拉2号构造圈闭形成于西域期, 成藏期晚. 下第三系厚层膏盐区域盖层形成的良好封盖条件及其成藏期晚是克拉2大气田得以很好保存的根本原因. 克拉2气田的异常高压是由于西域期来自北部的强烈构造挤压作用而形成的.     

Antibody neutralization and escape by HIV-1

Neutralizing antibodies (Nab) are a principal component of an effective human immune response to many pathogens, yet their role in HIV-1 infection is unclear. To gain a better understanding of this role, we examined plasma from patients with acute HIV infection. Here we report the detection of autologous Nab as early as 52 days after detection of HIV-specific antibodies. The viral inhibitory activity of Nab resulted in complete replacement of neutralization-sensitive virus by successive populations of resistant virus. Escape virus contained mutations in the env gene that were unexpectedly sparse, did not map generally to known neutralization epitopes, and involved primarily changes in N-linked glycosylation. This pattern of escape, and the exceptional density of HIV-1 envelope glycosylation generally, led us to postulate an evolving 'glycan shield' mechanism of neutralization escape whereby selected changes in glycan packing prevent Nab binding but not receptor binding. Direct support for this model was obtained by mutational substitution showing that Nab-selected alterations in glycosylation conferred escape from both autologous antibody and epitope-specific monoclonal antibodies. The evolving glycan shield thus represents a new mechanism contributing to HIV-1 persistence in the face of an evolving antibody repertoire.     

“名词”意义是否宽泛了点？

<中国科技术语>编辑部: 收到你们的<中国科技术语>第一期,非常感谢.读了这期文章,深感不仅是刊物名称的改动,也看到内容的拓宽与提高.     

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

Inhibition of the BRAF(V600E) oncoprotein by the small-molecule drug PLX4032 (vemurafenib) is highly effective in the treatment of melanoma. However, colon cancer patients harbouring the same BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to this drug. To investigate the cause of the limited therapeutic effect of PLX4032 in BRAF(V600E) mutant colon tumours, here we performed an RNA-interference-based genetic screen in human cells to search for kinases whose knockdown synergizes with BRAF(V600E) inhibition. We report that blockade of the epidermal growth factor receptor (EGFR) shows strong synergy with BRAF(V600E) inhibition. We find in multiple BRAF(V600E) mutant colon cancers that inhibition of EGFR by the antibody drug cetuximab or the small-molecule drugs gefitinib or erlotinib is strongly synergistic with BRAF(V600E) inhibition, both in vitro and in vivo. Mechanistically, we find that BRAF(V600E) inhibition causes a rapid feedback activation of EGFR, which supports continued proliferation in the presence of BRAF(V600E) inhibition. Melanoma cells express low levels of EGFR and are therefore not subject to this feedback activation. Consistent with this, we find that ectopic expression of EGFR in melanoma cells is sufficient to cause resistance to PLX4032. Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8-10% of all colon cancers), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors.     

高斯杂波中距离扩展目标的模糊CFAR检测

为提高高分辨雷达的检测性能,提出了一种高斯杂波背景下距离扩展目标的模糊检测方法。该方法采用模糊恒虚警率(constant false alarm rate, CFAR)检测器代替传统的二进制CFAR检测器,将距离单元值转换成映射到虚警空间的模糊隶属函数值,然后采用模糊积累准则进行积累,得到检测统计量。研究了模糊代数积、模糊代数和两种积累准则,推导出这两种方法虚警概率的数学解析式。仿真结果表明,高斯杂波背景下模糊代数积积累较双门限二进制积累可获得近2 dB的性能改善。同时,模糊检测方法只采用单个检测门限,具有易于调节的优点。     

Pr3+/Tm3+共掺LaF3纳米体系中能量转移效应的光谱学研究

在较低的温度下用水热法制备了分散性良好的Pr³⁺/Tm³⁺共掺的LaF₃纳米颗粒. X射线衍射、原子力显微镜和透射电子显微镜等技术对纳米颗粒进行表征的结果显示, 纳米颗粒呈六方相, 平均粒径为30 nm. 通过激光激发LaF3:Pr³⁺/Tm³⁺共掺纳米体系中的Tm3+离子, 实现了Tm³⁺离子到Pr³⁺离子的能量转移, 观测到了因此而产生的荧光辐射. 运用光谱学方法对共掺纳米体系的荧光辐射性质进行了研究分析, 并对相应的能量转移机理进行了探讨.     

直波导耦合输出AlGaInAs多量子阱环形激光器研究

采用InP基InAlGaAs多量子阱激光器外延材料结构, 利用感应耦合等离子体(ICP)干法刻蚀技术和聚酰亚胺介质平坦化工艺, 研制了多量子阱半导体环形激光器样品. 该器件通过加正偏压的环形结构谐振腔实现光激射, 然后借助紧邻的直线波导耦合将光信号输出. 环形谐振腔直径为700 μm, 波导宽度为3 μm. 用光纤对准直线波导端口耦合测试了环形激光器的光功率-电流特性曲线和激射光谱, 其阈值电流为120 mA, 在注入电流160 mA时从直波导耦合输出得到激射光谱的中心波长为1602 nm, 并结合光功率-电流特性曲线对环形激光器中的工作模式进行了初步分析.